TrialInvestigational new drugs2015

Randomized phase III trial of regorafenib in metastatic colorectal cancer: analysis of the CORRECT Japanese and non-Japanese subpopulations.

Takayuki Yoshino et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.